TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 Financial Results
November 07, 2016 07:30 ET
|
TearLab Corporation
SAN DIEGO, Nov. 07, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter and nine...
TearLab Corporation to Release Third Quarter 2016 Financial Results
October 20, 2016 16:15 ET
|
TearLab Corporation
SAN DIEGO, Oct. 20, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) will announce its third quarter 2016 financial results before the market opens...
TearLab and PRN Physician Recommended Nutriceuticals Announce Co-Promotion Agreement
October 13, 2016 16:05 ET
|
TearLab Corporation
Agreement leverages the combined strength of two leading brands in the management of Dry Eye Disease (DED)Co-promotion will utilize positive results from post-market clinical trial of Dry Eye Omega...
TearLab Announces Receipt of Nasdaq Staff Determination; Company to Request Hearing
September 16, 2016 17:54 ET
|
TearLab Corporation
SAN DIEGO, Sept. 16, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) today announced that on September 16, 2016, the Company received a letter from the Nasdaq...
TearLab Corporation to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016
August 29, 2016 08:30 ET
|
TearLab Corporation
SAN DIEGO, Aug. 29, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four...
TearLab Corporation Reports Second Quarter and June Year-To-Date 2016 Financial Results
August 03, 2016 16:01 ET
|
TearLab Corporation
SAN DIEGO, Aug. 03, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter and six...
TearLab Corporation to Release Second Quarter 2016 Financial Results
July 20, 2016 08:30 ET
|
TearLab Corporation
SAN DIEGO, July 20, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) will announce its second quarter 2016 financial results after market close on...
TearLab Corporation Comments on Shire plc FDA Approval of Xiidra™ (lifitegrast ophthalmic solution) 5%
July 12, 2016 16:01 ET
|
TearLab Corporation
SAN DIEGO, July 12, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”), a company that develops and markets point of care ophthalmic in-vitro...
TearLab Corporation Reports Q1-16 Financial Results
May 04, 2016 16:02 ET
|
TearLab Corporation
SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the first quarter ended...
TearLab Announces $17.3 Million Registered Public Offering
May 04, 2016 07:00 ET
|
TearLab Corporation
SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) announced today the pricing of a public offering of the Company’s common...